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Abstract
Background: The objective of this study was to investigate the effects of maternal high fat intake on intestinal
development and transcriptional profile.
Methods: Eight gilts with similar age and body weight were randomly allocated into 2 groups receiving the
control and high fat diets (HF diet) from d 30 to 90 of gestation, with 4 gilts each group and one gilt each pen. At
d 90 of gestation, two fetuses each gilt were removed by cesarean section. Intestinal samples were collected for
analysis of morphology, enzyme activities and transcriptional profile.
Results: The results showed that feeding HF diet markedly increased the fetal weight and lactase activity, also
tended to increase intestinal morphology. Porcine Oligo Microarray analysis indicated that feeding HF diet inhibited
64 % of genes (39 genes down-regulated while 22 genes up-regulated),which were related to immune response,
cancer and metabolism, also markedly modified 33 signal pathways such as antigen processing and presentation,
intestinal immune network for IgA production, Jak-STAT and TGF-ß signaling transductions, pathways in colorectal
cancer and glycerolipid metabolism.
Conclusion: Collectively, it could be concluded that maternal high fat intake was able to increase fetal weight and
lactase activity, however, it altered the intestinal immune response, signal transduction and metabolism.
Keywords: Maternal nutrition, Offspring, Immune, Cancer, DNA microarray
Background
Gastrointestinal tract (GIT), as an internal organ to di-
gest nutrients and resist exogenous antigens, starts to
develop at early gestation and mature rapidly in late
gestation for extra-uterine life [1]. The functional matur-
ation of GIT occurs in both pre- and postnatal period,
which is largely influenced by maternal nutrition [2].
Maternal diet has been shown to affect the fetal develop-
ment and organ function in mammalian animals [3].
Our recent study also suggests that maternal nutrition
levels could affect the intestinal development and function,
in which maternal over-nutrition would improve intestinal
morphology, enzyme activities and gene expressions of nu-
trient transporters in newborn pigs [4]. However, it has
been reported that maternal high-fat intake or –related
obesity could impair gut barrier, enhance gene expression
of pro-inflammatory cytokines in offspring intestine, thus
predisposes offspring to inflammatory bowel disease [5, 6].
However, the underlying mechanism for the effects of ma-
ternal high fat intake on the intestinal development and
function are limited. The current study was designed to
investigate the effects of maternal high fat intake on fetal
intestinal development and function by measuring parame-
ters on morphology, enzyme activities and transcriptional
profiles. Oligo Microarray was used to analyze the genomic
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response of fetal intestine to maternal high fat intake.
Pigs were chosen as the experimental animal, because it
is generally accepted to be closer to humans than other
laboratory or domestic animals in terms of gastrointestinal
anatomy, physiology, nutrition and microbiota [2, 7–9].
Methods
The experimental procedure was approved by the
University of Sichuan Agricultural Animal Care Advis-
ory committee, and followed the current law of animal
protection.
Animals and diets
A total of 8 Meishan (MS) gilts (aged at 266 ± 15 d, ini-
tial body weight at 73 ± 4 kg) were used in this study.
After inseminated with MS semen, eight gilts were ran-
domly allocated to receive control diet (CON diet with
14 % Protein, 34.7 % Starch and 2.8 % Fat) and high fat
diet (HF diet with 14 % Protein, 34.7 % Starch and 7.3 %
Fat), respectively. The 4.5 % of soy oil was added into
CON diet to formulate HF diet, as a result, HF diet con-
tained digestive energy (DE) at 3.0 Mcal/kg, while CON
diet contained DE at 2.6 Mcal/kg. According to the fatty
acids contents of feed ingredients by NRC (2012), the
contents of saturated, mono- and polyunsaturated fatty
acids were 0.25 %, 0.48 %, 0.83 % in CON diet and
0.84 %, 1.78 %, 3.44 % in HF diet, respectively. The other
nutrient levels were similar between 2 diets, meeting or
exceeding nutrient requirements recommended by NRC
(2012). All gilts were housed individually in stall (2.5 m
length × 1.6 m width), receiving the same amount of di-
ets at 2.0 kg from d 1 to 30 of gestation and 2.5 kg from
d 30 to 90 of gestation, with free access to water. Envir-
onmental temperature was maintained at approximately
24 °C during the experiment.
Sample collection
At d 90 of gestation, gilts were weighed (in average 128 kg
at HF vs. 117 kg at CON group) and anaesthetized by
intramuscularly injecting Zoletil 50 at the dose of 0.1 mg/
kg (Virbac, France), then the uterus were removed from
gilts. Two fetuses near the average fetal weight were col-
lected each gilt. As the previous study, duodenal, jejunal
and ileal samples (approximately 2 cm) were preserved in
4 % paraformaldehyde solution, then embedded in paraf-
fin. Each tissue sample of duodenum, jejunum and ileum
was used to prepare 5 slides, each slide had three sections
(5 mm thickness), which were stained with eosin and
haematoxylin, 20 well-oriented villi and crypts each sec-
tion were measured for morphology (Optimus software
version 6.5, Media Cybergenetics, North Reading, MA,
USA), and villous height to crypt depth ratio (VCR) was
calculated [10]. A section of duodenum, jejunum and
ileum tissues were collected and snap-frozen in liquid
nitrogen, then stored at −80 °C for analysis of enzyme ac-
tivities, RNA microarray and gene expression.
Enzyme activities
According to the previous study, the thawing samples of
jejunum and ileum were weighed (approximately 2 g),
then 9 times volume of 50 mM Tris–HCl buffer (pH 7 · 0)
than the sample weight were added and homogenized for
40 s by homogenate machine (Homogenizer Power Gen
125™, ThermoFisher Scientific, MA, USA) and centrifuged
at 3000 g for 10 min, the supernatant was collected and
stored at −20 °C [11]. Total protein was extracted from
the supernatant and protein concentration was deter-
mined by bicinchoninic acid protein assay with bovine
serum albumin as the standard (Solarbio, Inc., Beijing,
China). Activities of disaccharidase including maltase, su-
crase and lactase were measured using commercial kits
(Nanjing Jiancheng Bioengineering, Nanjing, China). The
absorbance at 450 nm was determined with spectropho-
tometer (Beckman Coulter DU-800; Beckman Coulter,
Inc., CA, USA). Activities of disaccharidase were pre-
sented as U/mg protein. One unit (U) was defined by
1 nmol of maltose, sucrose and lactose as a substrate for
the enzymatic reaction, respectively.
RNA extraction
The frozen ileum tissues were used for RNA extraction,
4 sections around luminal circle each tissue were col-
lected and pooled for RNA extraction. Total RNA was
extracted using Trizol reagent (Invitrogen, Carlsbad, CA,
USA) and quantified using spectrophotometry based on
absorbance at 260 nm, the RNA quality was monitored
using Agilent 2100 Bioanalyzer (Agilent Technologies,
Palo Alto, CA, USA). The equal amount of RNA from 2
fetus each gilt were pooled together.
Porcine oligo microarray
As in our previous study, Agilent Porcine Oligo Micro-
array (4 × 44 K) containing more than 40,000 probes
were used [12]. Cyanine-3 (Cy3)-labeled cRNA was pre-
pared from 0.5 μg RNA using the One-Color Low RNA
Input Linear Amplification PLUS kit (Agilent Technologie-
s,Palo Alto, CA, USA) according to the manufacturer’s in-
structions, and followed by the RNeasy column purification
(Qiagen, Valencia, CA, USA). Dye incorporation and cRNA
yield were checked with the NanoDrop ND-1000 Spectro-
photometer. Microarrays were hybridized at 65 °C for 17 h
and washed with a Gene Expression Washing Buffer Kit
(Agilent Technologies, Palo Alto, CA, USA). Slides were
scanned with an Agilent microarray scanner.
Microarray data collection and analysis
Microarray data were collected and analyzed using Agi-
lent G2567AA Feature Extraction software, following
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Agilent’s direct labeling protocol. The quantile method
was used to normalize the probe intensities across the
whole set of arrays. Three criteria were used to determine
statistically significant differential expression of intestinal
genes between fetus from CON and HF gilts: 1) statistical
significance: P value as determined by t-test < 0.05; 2)
Table 1 Primer sequences of genes selected for analysis by real-time RT-PCR
Genes GenBank accession Primer sequence (5′ ~ 3′) Product length (bp) Tm (°C)
HSPA1L NM_001123128.1 F:CGCTTTGACCTGACTGGAAT 120 60
R:CTTGCCTGTGCTCTTGTCC
CD8A NM_001001907.1 F:GCTGGACACCCGTTACATCT 100 60
R:CGAGCAGAAATAGTAGCCTTGG
CD40 NM_214194.1 F:GGTTCGTCTGCCTCTGAAGT 104 60
R:GGCTGTTTGTTGGGTATTGG
PSTPIP1 NM_001244186.1 F:CTCCTTTGACTCCCTGAAGC 114 60
R:TTCTGCCTCTCTCGGAACTC
SLA-DQA1 NM_001114062.2 F:TGGACCTGGAGAAGAAGGAG 132 60
R:TGGAGCGTTTAGTCACGATG
STAT2 NM_213889.1 F:TCCCAAATCACAAGGTTTCC 109 60
R:CAGATAGCCGAAGTCCCAAA
GK NM_001143708.1 F:GCAGGTAGATGGAGGGATGA 107 60
R:CCAGGGCAGTTGTTTCAGG
BMP7 NM_001105290.1 F:TCCAGGGCAAGCACAACT 172 60
R:TCGGTGAGGAAGTGGCTATC
PIK3R5 NM_213851.1 F:CTGTCATTCCCTCCTTCCAA 117 60
R:GCCACCCTCCTCTTACTCTG
SLA-DRB1 NM_001113695.1 F:TCTGCTCTTTGTTGCTGTGG 120 60
R:GGATGCTTGCTTGGAGTGTC
THY1 XM_005667396.1 F:GGCATCGCTCTCTTGCTAAC 125 60
R:GGCAGGTTGGTGGTATTCTC
TGFB1 NM_214015.1 F:AAGCGGCAACCAAATCTATG 113 60
R:CCCGAGAGAGCAATACAGGT
SLA-1 NM_001097431.1 F:GTCAAGGAAACCGCACAGAT 113 60
R:CCCAAGTAGCAGCCAAACAT
CD74 NM_213774.1 F:ATGGACGGTGTGAACTGGA 100 60
R:GAACCTCAAAGGGTGTCTCCT
SOD2 XM_005659113.1 F:CCTTCACTTTGCCTCTTGGT 127 60
R:CACCGTTAGGGCTCAGATTT
ACTA2 XM_005671254.1 F:GTCCACCTTCCAGCAAATGT 105 60
R:AGACAGCGAGCAGGGTAAGT
SULT1E1 NM_213992.1 F:TGAAGTCTCATCTGCCACCT 101 60
R:AGAAACGACCACATCCTTGG
β-actin DQ845171.1 F:GGCGCCCAGCACGAT 66 60
R:CCGATCCACACGGAGTACTTG
HSPA1L heat shock 70 kDa protein 1-like, CD8A CD8a molecule (CD8A), CD40 CD40 molecule, TNF receptor superfamily member 5; SLA-DQA1 MHC class II
histocompatibility antigen SLA-DQA, PSTPIP1 proline-serine-threonine phosphatase interacting protein 1, STAT2 signal transducer and activator of transcription 2,
GK glycerol kinase, BMP7 bone morphogenetic protein 7, PIK3R5 phosphoinositide-3-kinase, regulatory subunit 5, SLA-DRB1 MHC class II histocompatibility antigen
SLA-DRB1, THY1 Thy-1 cell surface antigen, TGFB1 transforming growth factor, beta 1, SLA-1 MHC class I antigen 1, CD74 CD74 molecule, major histocompatibility
complex, class II invariant chain, SOD2 superoxide dismutase 2, mitochondrial, ACTA2 actin, alpha 2, smooth muscle, aorta, SULT1E1 sulfotransferase family 1E,
estrogen-preferring, member 1
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reliability: a spot quality flag P (“P,” a quality flag assigned
by the software package); 3) relevance: a minimal fold
change between the means of the 2 groups >1.5.
Real-time PCR
In order to verify the microarray data, RNA samples used
for porcine oligo microarray were applied to the quantita-
tive real-time PCR (qPCR), which was performed in dupli-
cate to amplify the target and reference genes, using one
step SYBR Prime-Script™ RT-PCR kit II (Catalog no.
DRR086A, Takara, Japan) by Real-Time PCR (ABI
7900HT, Applied Biosystems, CA, USA). The sequences
of primers and length of products were shown at Table 1.
The reaction mixture (10.0 μL) contained 5.6 μL of freshly
pre-mixed one step SYBR Green Real-Time PCR Master
mix and Prime Script™ Enzyme Mix, 0.8 μmol/L of the
primers, and 100 ng of RNA template. The qPCR program
was designed with one cycle of 42 °C for 5 min, one cycle
of 95 °C for 10 s, 40 cycles of 95 °C for 5 s and 60 °C for
34 s, followed by the dissociation step at 95 °C for 15 s,
60 °C for 60 s and 95 °C for 15 s. At the end of amplifica-
tion, melting curve analysis was performed to identify
amplification specificity. Amplification of ß-actin was used
to normalize gene expression through the double standard
curves method [11].
Statistical analysis
The detected data by samples from two fetuses each gilt
were averaged and taken as one independent data in-
volving into statistical analysis model. In addition to
Oligo Microarray and qPCR data, all other data on
growth performance, intestinal morphology and enzyme
activities were analyzed via the t Student’s t test for a
completely randomized design using SAS (SAS, Cary,
NC). Results were expressed as the mean ± SD. Differ-
ences were considered to be significant when P <0.05,
while a tendency was considered when 0.05 < P < 0.10.
Results
Growth performance
Feeding HF diet markedly increased the fetal weight (in
average 585 g vs.508 g, P < 0.05) at d 90 of gestation.
Morphology and enzyme activities
Feeding HF diet tended to increase intestinal villous
height (P = 0.055), but decrease crypt depth (P = 0.098)
of fetus (Fig. 1). Meanwhile, the lactase activity was
markedly increased (+55 %, P < 0.05) by feeding HF diet
relative to CON diet, whereas the maltase activity did
not markedly differ between groups (Fig. 2), and sucrase
activity could not be detected in fetal intestine. Gene ex-
pression of digestive enzymes were not markedly differ
between two groups (Additional file 1).
Differentially expressed genes in fetal intestine
A total of 61 genes were differentially expressed (at least
1.5 fold change, P < 0.05), and 39 genes were down-
regulated while 22 genes were up-regulated (Table 2,
Fig. 3). The changes in mRNA expression detected by
porcine oligo microarrays were further validated by
Fig. 2 Effects of maternal high fat intake on digestive enzyme
activities of fetal intestine (n = 4). The symbol “*” in figure represents
there was significant difference at 5 % level (P < 0.05)
Fig. 1 Effect of maternal high fat intake on the intestinal morphology
of fetus (n = 4)
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Table 2 Maternal high fat intake markedly regulated intestinal gene expressions related to immune response, signal transduction,
cancer and metabolism
Gene Symbola Gene name Fold changeb P value
CCR7 chemokine (C-C motif) receptor 7 −2.94 0.023
HSPA1L heat shock 70 kDa protein 1-like −2.50 0.016
CD8A CD8a molecule (CD8A) −2.44 0.035
CD3E CD3e molecule, epsilon (CD3-TCR complex) (CD3E) −2.27 0.033
STK17B serine/threonine kinase 17b −2.00 0.026
CD40 CD40 molecule, TNF receptor superfamily member 5 −2.00 0.011
CD2 CD2 molecule −1.89 0.026
SLA-DQA1 MHC class II histocompatibility antigen SLA-DQA −1.85 0.002
PSTPIP1 proline-serine-threonine phosphatase interacting protein 1 −1.85 0.007
SLAMF6 SLAM family member 6 −1.82 0.046
TP53INP1 tumor protein p53 inducible nuclear protein 1 −1.82 0.000
FAM78A family with sequence similarity 78, member A −1.79 0.015
BCL2A1 BCL2-related protein A1 −1.79 0.023
ARHGAP25 Rho GTPase activating protein 25 −1.75 0.011
CD1.1 CD1 antigen −1.72 0.007
STAT2 signal transducer and activator of transcription 2 −1.69 0.042
ARHGAP30 Rho GTPase activating protein 30 −1.69 0.036
BCL2A1 BCL2-related protein A1 −1.69 0.040
IL10RB interleukin 10 receptor, beta −1.67 0.013
GK glycerol kinase −1.64 0.041
LTB mRNA, clone:MLN010057G03, expressed in mesenteric lymph nodes −1.64 0.031
LCP1 lymphocyte cytosolic protein 1 (L-plastin) −1.61 0.014
PGM1 phosphoglucomutase 1 −1.61 0.045
NRROS negative regulator of reactive oxygen species −1.59 0.049
CYTH4 cytohesin 4 −1.59 0.039
BMP7 bone morphogenetic protein 7 −1.59 0.024
PIK3R5 phosphoinositide-3-kinase, regulatory subunit 5 −1.56 0.009
RGS14 regulator of G-protein signaling 14 −1.54 0.049
GLRX glutaredoxin (thioltransferase) −1.54 0.025
SLA-DRB1 MHC class II histocompatibility antigen SLA-DRB1 −1.52 0.028
LPAR2 lysophosphatidic acid receptor 2 −1.52 0.016
THY1 Thy-1 cell surface antigen −1.52 0.028
TGFB1 transforming growth factor, beta 1 −1.52 0.022
BAZ1A bromodomain adjacent to zinc finger domain, 1A −1.52 0.024
CCDC69 coiled-coil domain containing 69 −1.49 0.048
LRRK2 leucine-rich repeat kinase 2 −1.49 0.022
SLA-1 MHC class I antigen 1 −1.49 0.018
CD74 CD74 molecule, major histocompatibility complex, class II invariant chain −1.49 0.038
SOD2 superoxide dismutase 2, mitochondrial 1.51 0.004
ILF2 interleukin enhancer binding factor 2 1.51 0.021
CYP39A1 cytochrome P450, family 39, subfamily A, polypeptide 1 1.52 0.043
JPH4 junctophilin 4 1.52 0.026
ATCAY ataxia, cerebellar, Cayman type 1.53 0.008
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qRT-PCR (Table 3). Given their participation in crucial
biological process and modulating signal pathways on
immune response, cancer and metabolism, these genes
were chosen for Real-Time PCR analysis.
Analysis of gene ontology and signal pathway
The differentially expressed genes were clustered ac-
cording to their biological process ontology by Gene
Ontology (GO) analysis from the SBS analysis system
(http://www.shanghaibiotech.com/). A large number of
these genes were associated with antigen processing
and presentation [i.e. D74, CD8A, SLA-DOB, SLA-DRB1,
SLA-DQA, HSPA1L], intestinal immune network for IgA
production [i.e. CD40, IL6, TGFβ1], Jak-STAT signaling
pathway [i.e. IL6, STAT2 and PIK3R5], TGF-ß signaling
pathway [i.e. TGF-β and PIK3R5], pathways in cancer [i.e.
LEF1, PIK3R5, NOS2] and glycerolipid metabolism [i.e.
GK, PNLIPRP1] et al. (Table 2, Fig. 4).
Consequently, maternal HF intake markedly modi-
fied 33 signal pathways (P < 0.01) (Table 4), which
were mainly involved in immune response (i.e. anti-
gen processing and presentation, intestinal immune
network for IgA production, primary immunodefi-
ciency), signaling transduction (i.e. TGF-ß signaling
pathway, chemokine signaling pathway), cancer (i.e.
colorectal cancer, pathways in cancer), metabolism
(i.e. glycerolipid metabolism, nitrogen metabolism),
signaling molecules and interaction (i.e. cytokine-cytokine
receptor interaction, cell adhesion molecules, neuroactive
ligand-receptor interaction).
Discussion
Some studies have indicated that maternal nutrition
would affect the intestinal development and function of
offspring [4, 13–15].
In this study, maternal high fat intake increased intes-
tinal villous height and lactase activity, which is similar
as our recent study that maternal over-nutrition
markedly increased birth weight, accordingly intestinal
morphology as well as lactase activity [4]. It may be ra-
tional that the heavier birth weight needs higher lactase
activity in preparation for better degradation of lactose,
which is a crucial energy source in neonatal period [16].
However, a recent study indicated that maternal high fat
intake would induce intestinal inflammation and poor
gut barrier function in the offspring of mice [5]. In this
study, porcine oligo miacro array analysis was used to
determine the genomic response of intestine to maternal
high fat intake, in an attempt to reveal the potential
mechanism. According to the strict selection criteria, we
found a total of 61 genes were differentially regulated
and 64 % of them (39 genes) was down-regulated by HF
diet. With the bioinformatics analysis, these down-
Table 2 Maternal high fat intake markedly regulated intestinal gene expressions related to immune response, signal transduction,
cancer and metabolism (Continued)
MATN2 mRNA, clone:OVR010041A03, expressed in ovary 1.53 0.016
CRMP1 Uncharacterized protein 1.54 0.039
RTDR1 mRNA, clone:UTR010010H08, expressed in uterus. 1.55 0.001
SPARCL1 SPARC-like 1 (hevin) 1.56 0.035
MATN2 mRNA, clone:OVR010041A03, expressed in ovary 1.56 0.019
CCN2 connective tissue growth factor 1.57 0.042
TUSC3 mRNA, clone: HTMT10103A12, expressed in hypothalamus 1.58 0.009
ID4 inhibitor of DNA binding 4, dominant negative helix-loop-helix protein 1.58 0.024
SPARC secreted protein, acidic, cysteine-rich (osteonectin) 1.60 0.035
MEP1A meprin A, alpha (PABA peptide hydrolase) 1.63 0.018
ARL10 ADP-ribosylation factor-like 10 1.64 0.036
STMN2 stathmin-like 2 1.64 0.039
ACTA2 actin, alpha 2, smooth muscle, aorta 1.66 0.016
SHISA2 shisa family member 2 1.76 0.029
UCHL1 ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) 1.79 0.014
OCRL oculocerebrorenal syndrome of Lowe 2.01 0.008
SULT1E1 sulfotransferase family 1E, estrogen-preferring, member 1 2.59 0.013
aGenes were selected from the Kyoto Encyclopedia of Genes and Genomes pathways related to intestinal immune response, signal transduction, cancer and
metabolism (http://www.genome.jp/kegg/pathway.html)
bThe fold change was based on the ratio of HF group to CON group, n = 4 subpools/group
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regulated genes were mainly involved in process of
immune response, signaling transduction, pathways in
cancer and metabolism, suggesting the inhibitory effects
of maternal high fat intake on certain biological events.
The maternal diet fat composition could change the
maternal-to-fetal fatty acid transfer and intestinal mem-
brane n-6 and n-3 fatty acids composition of newborns,
thus altering intestinal function [13]. In this study, there-
fore, it is rational that the addition of soy oil in maternal
diet would induce alterations in intestinal physiology of
fetus. Obviously, antigen processing and presentation in
intestine could be inhibited by feeding HF diet, as indi-
cated by the markedly decreasing gene expressions (i.e.
SLA-1, SLA -DRB1, SLA-DQA1, CD74 and CD8, 1.5 ~
2.5 fold reduction). Particularly, SLA-1, SLA -DRB1 and
SLA-DQA1 are belonged to the highly polymorphic
swine leucocyte antigen genes, which determine the im-
mune response to disease and vaccine [17]. Among
them, SLA-1 could interact with natural killer cells to
prevent cytotoxicity [18], while SLA-DRB1 and -DQA1
mainly present exogenous peptides for T cells [18, 19].
Previous studies have shown that maternal high fat
Fig. 3 Heatmap of the 61 differentially expressed genes. The HF
diet: s1_NS, s3-NS, s5-NS, s7-NS; The CON diet: s9_NS, s11-NS,
s13-NS, s15-NS
Table 3 Differentially expressed genes in fetal intestine by
maternal high fat intake and validated by qPCR
Fold changeb
Gene symbola cDNA Microarray qPCR P value
ACTA2 1.66 1.10 0.246
SULT1E1 2.59 1.88 0.002
SOD2 1.51 1.75 0.036
BMP7 −1.59 −1.09 0.722
CD40 −2.00 −1.74 0.116
CD74 −1.49 −1.36 0.029
CD8A −2.44 −1.85 0.049
GK −1.64 −1.33 0.041
HSPAIL −2.50 −1.60 0.027
PIK3R5 −1.56 −1.07 0.644
PSTPIP1 −1.85 −1.48 0.083
SLA-1 −1.49 −1.45 0.097
SLA-DQA1 −1.85 −1.79 0.003
SLA-DRB1 −1.52 −1.33 0.136
STAT2 −1.69 −1.18 0.125
TGF-β −1.52 −1.19 0.296
THY1 −1.52 −1.29 0.118
aGenes were selected on the basis of their crucial role on regulating intestinal
immune response (i.e.SLA-DRB1,SLA-DQA,HSPA1L,CD74,CD40), colorectal
cancer (i.e.TGF-β,PIK3R5), signal transduction (i.e. PSTPIP1,BMP7,STAT2) and
metabolism (i.e.GK, SULT1E1). These genes by DNA microarray were all
significantly regulated (P < 0.05, at least 1.5 fold change)
bThe fold change was based on the ratio of HF group to CON group,
n = 4 subpools/group
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intake impaired intestinal barrier and immune system
through altering immune cell homeostasis, such as the
number of T cells and macrophages [13]. Furthermore,
intestinal immune network for IgA production may be
impaired by HF diet, as shown by the decreasing gene
expression of CD40, IL-6 and TGF-ß. These genes
are required for B cells proliferation and differenti-
ation in Peyer’s patches, their down-regulation would
reduce the homing of T cells and IgA+ plasma cells
to the intestine, thus impair the immune homeostasis
of intestine [20, 21].
Several signal transduction pathways related to inflam-
matory and immune response were affected by maternal
high fat intake. For example, the TGF-β signaling pathway
was affected by HF diet, as indicated by the decreasing
gene expression of TGF-β and Bmp7 (approximately 1.6
fold reduction). TGF-β is a multifunctional factor regulat-
ing cell growth, adhesion and differentiation [22, 23], also
exerting anti-inflammatory effects by inhibiting NF-κB ex-
pression in the intestinal epithelium [24]. The oral admin-
istration of TGF-β has been shown to decrease severity
and incidence of necrotizing enterocolitis in neonatal rat
necrotizing enterocolitis model [24]. In addition, feeding
HF diet affected intestinal Jak-STAT signaling pathway, as
shown by the decreasing gene expression of IL6, STAT2
and PIK3R5. The Jak-STAT signaling pathway is required
for T cell differentiation, B cell maturation and secretion
of sIgA [25], these down-regulated genes by HF diet may
induce the abnormal intestinal innate immune response.
Similarly, previous study demonstrated that maternal high
protein diet would decrease liver mass, associated with al-
tering gene expressions mapping to Jak-STAT signaling
pathway in mouse offspring [26].
Furthermore, the lower expressions of TGF-β and
PIK3R5 genes by HF diet may affect the progression of
colorectal cancer. TGF-β1/Smads signaling pathway was
demonstrated to mediate epithelial-to-mesenchymal
transition, associated with the progression of colorectal
cancer [27]. Mutation of PIK3R5 and other genes (i.e.
PRKCZ, PTEN, RHEB and RPS6KB1) have altered PI3K
signaling pathway, which is the central pathway for both
colorectal and breast cancers [28]. Recent studies also
indicated that maternal high fat diet would modify the
susceptibility to breast cancer [29, 30], meanwhile it is
dependent on fat or oil sources [31–33].
In this study, moreover, the markedly reduced glycerol
kinase by feeding HF diet suggests the intestinal metabol-
ism was altered. Glycerol kinase is required to release gly-
cerol from glycerol-3-phosphate and dihydroxyacetone,
and intestinal glycerol could produce 20 ~ 25 % of total
endogenous glucose under insulinopenia, suggesting the
important role of glycerol in intestinal metabolism [34].
Although most of genes were markedly down-regulated
by HF diet, some of genes (SOD2, CYP39A1, CCN2,
SPARC et al.) were up-regulated. Particularly, SOD2, as
an anti-oxidative enzyme in living cells, was highly
expressed (1.75 fold change, P = 0.04). Likewise, a recent
study demonstrated that maternal high energy intake
increased the expression of SOD in offspring ileum [5].
Previous study indicated that the increasing SOD gene
is not necessarily associated with a better antioxidant
capability, for example, the inflamed intestinal mucosa
has been shown to contain higher SOD protein com-
pared with normal tissues [35]. In addition, we found
that feeding HF diet markedly increased gene expres-
sion of SULT1E by both DNA Microarray and RT-PCR
analysis. SULT1E, as an estrogen-preferring drug me-
tabolizing enzyme, its highly expression may be an com-
pensatory response to high circulating estrogen, which
occurs in dams fed high fat diet [36]. It has been shown
Fig. 4 Signal pathway enrichment analysis of fetal intestine by HF diet relative to CON diet (n = 4 subpools/group). The pathway terms were
according to the down-regulated genes for certain biological processes, enriched categories are those identified as significantly enriched after
multiple testing. * P < 0.05, ** P < 0.01. The value by horizontal axis resulted from negative value of Log (enrichment test P value, base 10)
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that the estrogen deletion by SULT1E over-expression is
associated with the risk of developing different types of
cancers [28, 37].
Conclusion
In summary, maternal high fat intake was able to increase
fetal and intestinal weights as well as lactase activity, how-
ever, it altered the intestinal immune response, signal
transduction and metabolism.
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Additional file 1: Effect of maternal high fat intake on gene expression
of digestive enzymes in fetal intestine. (DOCX 34 kb)
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
The authors’ contributions are as follows: L-QC contributed to the study design
and manuscript preparation; PLL, ZGY and LC carried out the study; LH, LLQ
Table 4 The markedly modified signal pathways in fetal intestine of gilts fed HF diet
Name Hits a Total b Percent Enrichment test
p value
Allograft rejection 6 34 17.65 % 0.000
Antigen processing and presentation 8 64 12.50 % 0.000
Autoimmune thyroid disease 6 45 13.33 % 0.000
Cell adhesion molecules 8 71 11.27 % 0.000
Cytokine-cytokine receptor interaction 10 142 7.04 % 0.000
Hematopoietic cell lineage 7 63 11.11 % 0.000
Intestinal immune network for IgA production 7 48 14.58 % 0.000
Leishmania infection 8 63 12.70 % 0.000
Viral myocarditis 9 46 19.57 % 0.000
Graft-versus-host disease 6 57 10.53 % 1E-04
Neuroactive ligand-receptor interaction 10 174 5.75 % 1E-04
Type I diabetes mellitus 5 40 12.50 % 2E-04
Asthma 5 50 10.00 % 5E-04
Jak-STAT signaling pathway 6 82 7.32 % 6E-04
Primary immunodeficiency 4 37 10.81 % 0.0013
Pathways in cancer 7 140 5.00 % 0.0017
Hypertrophic cardiomyopathy 4 43 9.30 % 0.0022
Systemic lupus erythematosus 5 86 5.81 % 0.0043
Adipocytokine signaling pathway 4 55 7.27 % 0.005
Chemokine signaling pathway 5 90 5.56 % 0.0052
Colorectal cancer 3 31 9.68 % 0.0072
Fc gamma R-mediated phagocytosis 3 32 9.38 % 0.0078
T cell receptor signaling pathway 4 63 6.35 % 0.0078
Leukocyte transendothelial migration 4 71 5.63 % 0.0115
Acute myeloid leukemia 3 39 7.69 % 0.0129
Dilated cardiomyopathy 3 40 7.50 % 0.0137
Glycerolipid metabolism 3 41 7.32 % 0.0146
Arrhythmogenic right ventricular cardiomyopathy 3 47 6.38 % 0.0205
Nitrogen metabolism 2 19 10.53 % 0.0246
TGF-beta signaling pathway 3 55 5.45 % 0.0302
Endometrial cancer 2 22 9.09 % 0.0316
Aldosterone-regulated sodium reabsorption 2 24 8.33 % 0.0366
Type II diabetes mellitus 2 24 8.33 % 0.0366
aHits mean the number of differential expressed genes within the particular GO term
bTotal: the total number of genes within the particular GO term
Che et al. Lipids in Health and Disease  (2016) 15:90 Page 9 of 10
and RW contributed to the sample analysis; ZFF, YL, JL and SYX contributed to
the data analysis; BF and DW contributed to the data interpretation. All authors
read and approved the final manuscript.
Acknowledgements
We would like to thank the staff at our laboratory for their ongoing assistance.
Funding
The present study was supported by the National Natural Science Foundation
of China (31101727) and the National Basic Research Program (973 Program) of
China (No. 2013CB127306).
Received: 21 February 2016 Accepted: 3 May 2016
References
1. Wu G, Bazer FW, Wallace JM, Spencer TE. Board-invited review: intrauterine
growth retardation: implications for the animal sciences. J Anim Sci. 2006;84:
2316–37.
2. Sangild PT. Gut responses to enteral nutrition in preterm infants and
animals. Exp Biol Med (Maywood). 2006;231:1695–711.
3. Pinheiro DF, Pinheiro PF, Buratini Jr J, Castilho AC, Lima PF, Trinca LA,
Vicentini-Paulino Mde L. Maternal protein restriction during pregnancy
affects gene expression and immunolocalization of intestinal nutrient
transporters in rats. Clin Sci (Lond). 2013;125:281–9.
4. Cao M, Che L, Wang J, Yang M, Su G, Fang Z, Lin Y, Xu S, Wu D. Effects of
maternal over- and undernutrition on intestinal morphology, enzyme
activity, and gene expression of nutrient transporters in newborn and
weaned pigs. Nutrition. 2014;30:1442–7.
5. Xue Y, Wang H, Du M, Zhu MJ. Maternal obesity induces gut inflammation
and impairs gut epithelial barrier function in nonobese diabetic mice. J Nutr
Biochem. 2014;25:758–64.
6. Yan X, Huang Y, Wang H, Du M, Hess BW, Ford SP, Nathanielsz PW, Zhu MJ.
Maternal obesity induces sustained inflammation in both fetal and offspring
large intestine of sheep. Inflamm Bowel Dis. 2011;17:1513–22.
7. Gonzalez-Bulnes A, Astiz S, Ovilo C, Lopez-Bote CJ, Sanchez-Sanchez R, Perez-
Solana ML, Torres-Rovira L, Ayuso M, Gonzalez J. Early-postnatal changes in
adiposity and lipids profile by transgenerational developmental programming
in swine with obesity/leptin resistance. J Endocrinol. 2014;223:M17–29.
8. Zhang Q, Widmer G, Tzipori S. A pig model of the human gastrointestinal
tract. Gut Microbes. 2013;4:193–200.
9. Heinritz SN, Mosenthin R, Weiss E. Use of pigs as a potential model for
research into dietary modulation of the human gut microbiota. Nutr Res
Rev. 2013;26:191–209.
10. Han F, Hu L, Xuan Y, Ding X, Luo Y, Bai S, He S, Zhang K, Che L. Effects of high
nutrient intake on the growth performance, intestinal morphology and
immune function of neonatal intra-uterine growth-retarded pigs. Br J Nutr.
2013;110:1819–27.
11. Hu L, Liu Y, Yan C, Peng X, Xu Q, Xuan Y, Han F, Tian G, Fang Z, Lin Y, et al.
Postnatal nutritional restriction affects growth and immune function of
piglets with intra-uterine growth restriction. Br J Nutr. 2015;114:53–62.
12. Che L, Chen H, Yu B, He J, Zheng P, Mao X, Yu J, Huang Z, Chen D. Long-
term intake of pea fiber affects colonic barrier function, bacterial and
transcriptional profile in pig model. Nutr Cancer. 2014;66:388–99.
13. Innis SM, Dai C, Wu X, Buchan AM, Jacobson K. Perinatal lipid nutrition
alters early intestinal development and programs the response to
experimental colitis in young adult rats. Am J Physiol Gastrointest Liver
Physiol. 2010;299:G1376–1385.
14. Boudry G, Douard V, Mourot J, Lalles JP, Le Huerou-Luron I. Linseed oil in
the maternal diet during gestation and lactation modifies fatty acid
composition, mucosal architecture, and mast cell regulation of the ileal
barrier in piglets. J Nutr. 2009;139:1110–7.
15. Desaldeleer C, Ferret-Bernard S, de Quelen F, Le Normand L, Perrier C, Savary
G, Rome V, Michel C, Mourot J, Le Huerou-Luron I, Boudry G. Maternal 18:3n-3
favors piglet intestinal passage of LPS and promotes intestinal anti-
inflammatory response to this bacterial ligand. J Nutr Biochem. 2014;25:1090–8.
16. Heyman MB, Committee on N. Lactose intolerance in infants, children, and
adolescents. Pediatrics. 2006;118:1279–86.
17. Ho CS, Lunney JK, Lee JH, Franzo-Romain MH, Martens GW, Rowland RR,
Smith DM. Molecular characterization of swine leucocyte antigen class II
genes in outbred pig populations. Anim Genet. 2010;41:428–32.
18. Lunney JK, Ho CS, Wysocki M, Smith DM. Molecular genetics of the swine
major histocompatibility complex, the SLA complex. Dev Comp Immunol.
2009;33:362–74.
19. Summerfield A, Guzylack-Piriou L, Schaub A, Carrasco CP, Tache V, Charley B,
McCullough KC. Porcine peripheral blood dendritic cells and natural
interferon-producing cells. Immunology. 2003;110:440–9.
20. Wang D, Dubois RN, Richmond A. The role of chemokines in intestinal
inflammation and cancer. Curr Opin Pharmacol. 2009;9:688–96.
21. Chu VT, Beller A, Rausch S, Strandmark J, Zanker M, Arbach O, Kruglov A,
Berek C. Eosinophils promote generation and maintenance of
immunoglobulin-A-expressing plasma cells and contribute to gut immune
homeostasis. Immunity. 2014;40:582–93.
22. Massagué J. TGFβ in cancer. Cell. 2008;134:215–30.
23. Van’t Land B, Meijer H, Frerichs J, Koetsier M, Jager D, Smeets R, M'Rabet L,
Hoijer M. Transforming Growth Factor-β2 protects the small intestine during
methotrexate treatment in rats possibly by reducing stem cell cycling. Br J
Cancer. 2002;87:113–8.
24. Shiou SR, Yu Y, Guo Y, Westerhoff M, Lu L, Petrof EO, Sun J, Claud EC. Oral
administration of transforming growth factor-beta1 (TGF-beta1) protects the
immature gut from injury via Smad protein-dependent suppression of
epithelial nuclear factor kappaB (NF-kappaB) signaling and proinflammatory
cytokine production. J Biol Chem. 2013;288:34757–66.
25. Heneghan AF, Pierre JF, Kudsk KA. JAK-STAT and intestinal mucosal
immunology. JAKSTAT. 2013;2:e25530.
26. Vanselow J, Kucia M, Langhammer M, Koczan D, Rehfeldt C, Metges CC.
Hepatic expression of the GH/JAK/STAT/IGF pathway, acute-phase response
signalling and complement system are affected in mouse offspring by
prenatal and early postnatal exposure to maternal high-protein diet. Eur J
Nutr. 2011;50:611–23.
27. Ji Q, Liu X, Han Z, Zhou L, Sui H, Yan L, Jiang H, Ren J, Cai J, Li Q.
Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal
cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin
expression. BMC Cancer. 2015;15:1.
28. Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, Leary RJ, Shen D, Boca SM,
Barber T, Ptak J. The genomic landscapes of human breast and colorectal
cancers. Science. 2007;318:1108–13.
29. Montales MT, Melnyk SB, Simmen FA, Simmen RC. Maternal metabolic
perturbations elicited by high-fat diet promote Wnt-1-induced mammary
tumor risk in adult female offspring via long-term effects on mammary and
systemic phenotypes. Carcinogenesis. 2014;35:2102–12.
30. de Oliveira AF, Fontelles CC, Rosim MP, de Oliveira TF, de Melo Loureiro AP,
Mancini-Filho J, Rogero MM, Moreno FS, de Assis S, Barbisan LF, et al.
Exposure to lard-based high-fat diet during fetal and lactation periods
modifies breast cancer susceptibility in adulthood in rats.
J Nutr Biochem. 2014;25:613–22.
31. Mabasa L, Cho K, Walters MW, Bae S, Park CS. Maternal dietary canola oil
suppresses growth of mammary carcinogenesis in female rat offspring. Nutr
Cancer. 2013;65:695–701.
32. Czuba AK, Mazurkiewicz M, Stanimirova-Daszykowska I. Enrichment of maternal
diet with conjugated linoleic acids influences desaturases activity and fatty acids
profile in livers and hepatic microsomes of the offspring with 7, 12-dimethylbenz
[a] anthracene-induced mammary tumors. Acta Pol Pharm. 2014;71:747.
33. Su H-M, Hsieh P-H, Chen H-F. A maternal high n-6 fat diet with fish oil
supplementation during pregnancy and lactation in rats decreases breast
cancer risk in the female offspring. J Nutr Biochem. 2010;21:1033–7.
34. Croset M, Rajas F, Zitoun C, Hurot J-M, Montano S, Mithieux G. Rat small
intestine is an insulin-sensitive gluconeogenic organ. Diabetes. 2001;50:740–6.
35. Kruidenier L, Kuiper I, van Duijn W, Marklund SL, van Hogezand RA, Lamers CB,
Verspaget HW. Differential mucosal expression of three superoxide dismutase
isoforms in inflammatory bowel disease. J Pathol. 2003;201:7–16.
36. Hilakivi-Clarke L, Clarke R, Onojafe I, Raygada M, Cho E, Lippman M. A
maternal diet high in n − 6 polyunsaturated fats alters mammary gland
development, puberty onset, and breast cancer risk among female rat
offspring. Proc Natl Acad Sci. 1997;94:9372–7.
37. Sharda DR, Miller-Lee JL, Kanski GM, Hunter JC, Lang CH, Kennett MJ,
Korzick DH. Comparison of the agar block and Lieber–DeCarli diets to study
chronic alcohol consumption in an aging model of Fischer 344 female rats.
J Pharmacol Toxicol Methods. 2012;66:257–63.
Che et al. Lipids in Health and Disease  (2016) 15:90 Page 10 of 10
